Suit Alleges Biotech Firm Lied About FDA Trials
Trouble continues to mount for the biotechnology company Dendreon Corp. since it announced in May that the U.S. Food and Drug Administration asked for more information regarding its advanced prostate cancer...To view the full article, register now.
Already a subscriber? Click here to view full article